Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04658420Phase 2Unknown
Phase 2, randomised, open-label trial of ketamine in suicidal ideation (4 arms), sponsored by The University of Texas Health Science Center at Tyler. Primary endpoint: Scale for Suicide Ideation at 4 weeks. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04658420.